A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 77,728 shares of GRFS stock, worth $583,737. This represents 0.13% of its overall portfolio holdings.

Number of Shares
77,728
Previous 19,556 297.46%
Holding current value
$583,737
Previous $123,000 460.98%
% of portfolio
0.13%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.28 - $9.38 $365,320 - $545,653
58,172 Added 297.46%
77,728 $690,000
Q1 2024

May 14, 2024

SELL
$5.47 - $11.38 $592,674 - $1.23 Million
-108,350 Reduced 84.71%
19,556 $130,000
Q4 2022

Feb 13, 2023

SELL
$5.96 - $8.53 $26,224 - $37,532
-4,400 Reduced 3.33%
127,906 $1.09 Million
Q1 2022

May 13, 2022

SELL
$10.37 - $12.73 $416,894 - $511,771
-40,202 Reduced 23.3%
132,306 $1.55 Million
Q2 2021

Aug 13, 2021

SELL
$16.62 - $18.94 $538,687 - $613,883
-32,412 Reduced 15.82%
172,508 $2.99 Million
Q1 2021

May 14, 2021

SELL
$15.15 - $19.78 $1.89 Million - $2.46 Million
-124,604 Reduced 37.81%
204,920 $3.54 Million
Q4 2020

Feb 05, 2021

BUY
$16.86 - $19.67 $155,112 - $180,964
9,200 Added 2.87%
329,524 $6.08 Million
Q3 2020

Nov 06, 2020

BUY
$15.4 - $20.16 $328,836 - $430,476
21,353 Added 7.14%
320,324 $5.56 Million
Q2 2020

Aug 13, 2020

SELL
$18.24 - $21.45 $1.85 Million - $2.17 Million
-101,300 Reduced 25.31%
298,971 $5.45 Million
Q1 2020

May 14, 2020

BUY
$16.28 - $25.63 $162,800 - $256,300
10,000 Added 2.56%
400,271 $8.06 Million
Q3 2019

Nov 01, 2019

BUY
$19.85 - $22.76 $246,140 - $282,224
12,400 Added 3.28%
390,271 $7.83 Million
Q2 2019

Aug 02, 2019

BUY
$17.59 - $21.1 $1.53 Million - $1.83 Million
86,700 Added 29.78%
377,871 $7.97 Million
Q1 2019

May 02, 2019

BUY
$18.01 - $20.11 $232,329 - $259,419
12,900 Added 4.64%
291,171 $5.86 Million
Q4 2018

Jan 30, 2019

SELL
$17.44 - $21.53 $669,347 - $826,321
-38,380 Reduced 12.12%
278,271 $5.11 Million
Q3 2018

Nov 02, 2018

BUY
$19.97 - $21.96 $302,964 - $333,155
15,171 Added 5.03%
316,651 $6.77 Million
Q2 2018

Aug 10, 2018

BUY
$20.16 - $24.68 $6.08 Million - $7.44 Million
301,480 New
301,480 $6.48 Million
Q1 2018

May 09, 2018

SELL
$20.31 - $24.95 $1.41 Million - $1.73 Million
-69,275 Closed
0 $0
Q4 2017

Feb 02, 2018

SELL
$20.99 - $23.89 $4.07 Million - $4.63 Million
-193,900 Reduced 73.68%
69,275 $1.59 Million
Q3 2017

Nov 01, 2017

BUY
$20.07 - $21.89 $5.28 Million - $5.76 Million
263,175
263,175 $5.76 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.1B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.